Literature DB >> 30989328

Efficacy and safety of endovascular therapy by diluted contrast digital subtraction angiography in patients with chronic kidney disease.

Naoki Hayakawa1, Satoshi Kodera2,3, Noriyoshi Ohki4, Junji Kanda2.   

Abstract

This study was performed to evaluate the efficacy and safety of endovascular therapy (EVT) by diluted contrast digital subtraction angiography (DSA) in patients with chronic kidney disease (CKD). Patients with peripheral artery disease (PAD) often have CKD; thus, EVT carries a risk of contrast-induced nephropathy (CIN). Reducing the amount of contrast medium is, therefore, important in these patients. We developed a novel EVT method using DSA with diluted contrast medium. DSA parameters were adjusted for diluted contrast angiography (1:10 dilution), and we defined this technique as low-concentration DSA (LC-DSA). We retrospectively analyzed 122 patients with CKD [estimated glomerular filtration rate (eGFR), < 45 mL/min/1.73 m2] from June 2012 to November 2017 and classified them into two groups: EVT with diluted contrast (LC-DSA group, n = 63) and conventional EVT (control group, n = 59). Patients with aortoiliac lesions and those undergoing hemodialysis were excluded. The primary endpoint was the incidence of CIN as defined by an absolute increase in serum creatinine of ≥ 0.5 mg/dL or relative increase of ≥ 25% 2-5 days after the procedure. The secondary endpoints were worsening renal function (defined as an eGFR reduction of ≥ 25% compared with that before the procedure), the amount of contrast medium used for EVT, freedom from complications related to LC-DSA, and procedural success. The incidence of CIN was significantly lower in the LC-DSA group than control group (0.0% vs. 11.9%, respectively; P = 0.001). The absolute eGFR increase (4.25 ± 4.7 vs. 1.24 ± 6.9, respectively; P = 0.005) and creatinine decrease ( - 0.16 ± 0.2 vs. 0.007 ± 0.34, respectively; P = 0.0078) were greater in the LC-DSA group than control group. Less contrast medium was used in the LC-DSA group than control group (30.0 ± 14.6 vs. 117.9 ± 52.8 mL, respectively; P < 0.0001). There were no differences in the procedural success rate (100% vs. 96.6%, P = 0.23) or complications related to LC-DSA (0.0% vs. 1.7%, P = 0.48). Therefore, we concluded that EVT with diluted contrast DSA reduced the amount of contrast medium and incidence of CIN. This method is effective and safe for treating patients with CKD who have infrainguinal lesions.

Entities:  

Keywords:  Chronic kidney disease; Contrast-induced nephropathy; Digital subtraction angiography; Diluted contrast medium; Endovascular therapy

Mesh:

Substances:

Year:  2019        PMID: 30989328     DOI: 10.1007/s00380-019-01412-2

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  25 in total

1.  Ultra-low-dose intra-arterial contrast injection for iliofemoral computed tomographic angiography.

Authors:  Subodh B Joshi; Dorinna D Mendoza; Daniel H Steinberg; Matthew A Goldstein; Cristian F Lopez; Arnold Raizon; Gaby Weissman; Lowell F Satler; Augusto D Pichard; Wm Guy Weigold
Journal:  JACC Cardiovasc Imaging       Date:  2009-12

Review 2.  CO2 digital subtraction angiography: potential complications and their prevention.

Authors:  J G Caridi; I F Hawkins
Journal:  J Vasc Interv Radiol       Date:  1997 May-Jun       Impact factor: 3.464

3.  Impact of CT parameters on the physical quantities related to image quality for two MDCT scanners using the ACR accreditation phantom: A phantom study.

Authors:  B Alikhani; L Jamali; H-J Raatschen; F Wacker; T Werncke
Journal:  Radiography (Lond)       Date:  2017-04-04

4.  Safety and efficacy of endovascular therapy with a simple homemade carbon dioxide delivery system in patients with ileofemoral artery diseases.

Authors:  Daizo Kawasaki; Kenichi Fujii; Masashi Fukunaga; Motomaru Masutani; Aya Nakata; Tohru Masuyama
Journal:  Circ J       Date:  2012-04-14       Impact factor: 2.993

5.  Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.

Authors:  José Mariani; Cristiano Guedes; Paulo Soares; Silvio Zalc; Carlos M Campos; Augusto C Lopes; André G Spadaro; Marco A Perin; Antonio Esteves Filho; Celso K Takimura; Expedito Ribeiro; Roberto Kalil-Filho; Elazer R Edelman; Patrick W Serruys; Pedro A Lemos
Journal:  JACC Cardiovasc Interv       Date:  2014-10-15       Impact factor: 11.195

6.  Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial.

Authors:  Jeffrey W H Fung; C C Szeto; Wilson W M Chan; Leo C C Kum; Anna K Y Chan; John T H Wong; Eugene B Wu; Gabriel W K Yip; Joseph Y S Chan; Cheuk M Yu; Kam S Woo; John E Sanderson
Journal:  Am J Kidney Dis       Date:  2004-05       Impact factor: 8.860

7.  Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.

Authors:  Konstantinos Spargias; Elias Adreanides; Eftihia Demerouti; Angeliki Gkouziouta; Athanassios Manginas; Gregory Pavlides; Vassilis Voudris; Dennis V Cokkinos
Journal:  Circulation       Date:  2009-10-19       Impact factor: 29.690

8.  Reduction of radiation exposure associated with renewal of the radiologic systems in coronary interventions.

Authors:  J-L Georges; Z Boueri; B Mailler; O Nallet; D Millischer; A Faure; P F Massiani; L Belle; L Chapoutot; B Girodet; S Cattan
Journal:  Ann Cardiol Angeiol (Paris)       Date:  2018-10-02

Review 9.  Carbon dioxide in angiography to reduce the risk of contrast-induced nephropathy.

Authors:  Irvin F Hawkins; Kyung J Cho; James G Caridi
Journal:  Radiol Clin North Am       Date:  2009-09       Impact factor: 2.303

10.  Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine.

Authors:  Steven D Weisbord; Martin Gallagher; Hani Jneid; Santiago Garcia; Alan Cass; Soe-Soe Thwin; Todd A Conner; Glenn M Chertow; Deepak L Bhatt; Kendrick Shunk; Chirag R Parikh; Edward O McFalls; Mary Brophy; Ryan Ferguson; Hongsheng Wu; Maria Androsenko; John Myles; James Kaufman; Paul M Palevsky
Journal:  N Engl J Med       Date:  2017-11-12       Impact factor: 176.079

View more
  3 in total

1.  Efficacy of three-dimensional roadmapping by fusion of computed tomography angiography with volumetric data from an angiography machine in endovascular therapy for iliac chronic total occlusion: a case report.

Authors:  Naoki Hayakawa; Satoshi Kodera; Noriyoshi Ohki; Junji Kanda
Journal:  CVIR Endovasc       Date:  2019-10-21

2.  Emergency angiography for trauma patients and potential association with acute kidney injury.

Authors:  Ryo Yamamoto; Ramon F Cestero; Jo Yoshizawa; Katsuya Maeshima; Junichi Sasaki
Journal:  World J Emerg Surg       Date:  2021-11-04       Impact factor: 5.469

Review 3.  [General Treatment Strategy for Intervention in Lower Extremity Arterial Disease].

Authors:  Je Hwan Won
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-05-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.